Supplementary Table S4 from SALVO: Single-Arm...

Supplementary Table S4 from SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma

Abstract

<p>Outcomes by Subgroups of Primary Site, Adjuvant Radiation, and R0/R1 Resection Margin Status</p>

Kottschade LA; Pond GR; Olszanski AJ; Zakharia Y; Domingo-Musibay E; Hauke RJ; Curti BD; Schober S; Milhem MM; Block MS

April 25, 2023

10.1158/1078-0432.22692626.v1

Gregory Pond